Immunic, Inc.
(NASDAQ : IMUX)

( )
IMUX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
ABBVAbbVie, Inc. -0.96%92.131.9%$1192.97m
JNJJohnson & Johnson -0.87%144.440.7%$1057.09m
BMYBristol-Myers Squibb Co. -0.57%60.791.0%$967.46m
PFEPfizer Inc. 0.64%37.500.9%$831.88m
MRKMerck & Co., Inc. -0.22%76.380.7%$796.50m
LLYEli Lilly & Co. -0.69%151.231.1%$417.06m
AZNAstraZeneca Plc -0.11%55.221.2%$261.94m
NVSNovartis AG -0.09%84.910.2%$156.50m
GSKGlaxoSmithKline Plc -0.37%40.880.2%$140.53m
BHCBausch Health Cos., Inc. -2.26%17.770.0%$116.19m
NVONovo Nordisk A/S 0.05%64.850.1%$87.00m
SNYSanofi -0.30%47.300.2%$78.78m
RGENRepligen Corp. -0.57%139.517.1%$73.05m
ARCTArcturus Therapeutics Holdings, Inc. 7.71%58.270.0%$60.48m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 11.80%58.370.0%$42.40m

Company Profile

Immunic, Inc. develops a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. It focuses on ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. Its products include IMU-838, IMU-935, and IMU-856. The company is headquartered in San Diego, CA.